| Source of record | UK Trials |
| ISRCTN | ISRCTN63003238 |
| Date ISRCTN assigned | 19/12/2007 |
| Local reference number(s) | RAP study 2007 |
| Public title | A randomised controlled pilot study to assess the benefit of using Reiki to treat chronic plaque psoriasis |
| Scientific title |
|
| Acronym | RAP |
| Disease/condition/study domain | Chronic plaque psoriasis |
| Study hypothesis | That the use of Reiki healing treament of moderate to severe psoriasis is measurably effective and the same results are able to be reproduced by any Reiki II practitioner. |
| Design/methodology | Randomised controlled trial |
| Research ethics review | Ethics approval received from the Devon and Torbay Research Ethics Committee (REC) on the 4th October 2007 (ref: 07/H0202/108). |
| Countries of trial | United Kingdom |
| Participants - inclusion criteria | 1. Patients who suffer from stable chronic plaque psoriasis that would be appropriate for treatment by topical agents
2. Informed consent
3. Adults aged 18 years or over, male or female |
| Participants - exclusion criteria | 1. Pregnant women
2. Patients with severe disease
3. Patients with unstable psoriasis and putular psoriasis
4. Patients who have already experienced healing
5. Unable to give informed consent |
| Patient information material |
|
| Anticipated start date | 15/10/2007 |
| Anticipated end date | 30/09/2009 |
| Status of trial | Ongoing |
| Target number of participants | 30 |
| Interventions | Arm A: conventional topical treatment (as per current local practice may include the following: emollients, vitamin D creams and ointments [calcipotriol etc.], tar preparations [Alphosyl and Exorex] and topical steroids or combinations of the above - applied twice daily as per instructions per standard practice, dependant on the topical treatment of choice) and five Reiki treatments given over a 3 month period.
Arm B: five consecutive reiki treatments only over 3 months but advised to continue using moisturisers. |
| Primary outcome measure(s) | 1. Physical Assessment: using the Psoriasis Area and Severity Index (PASI) assessment tool, validated by photographic evidence
2. Quality of Life Assessments with Dermatology Life Quality Index (DLQI) to show to which degree the psoriasis affects the patient's normal activities
3. Psychological assessment (12-item General Health Questionnaire [GHQ12]) to show if there has been any general improvement in the quality of life, regardless of the state of psoriasis
4. Health Economics Assessment |
| Secondary outcome measure(s) | 1. The Healing Assessment (HA) 1.1 will identify any possible trends in psychological triggers
2. The Healing Assessment (HA) 2.1 will be used to assess the relevance of any unusual experiences during treatment and to note the areas of the body which the healer feels may require extra attention |
| Sources of funding | Newton Abbott Hospital League of Friends (UK) |
| Sponsor name | South Devon Healthcare NHS Foundation Trust (UK) |
| Sponsor details | Torbay Hospital
Lawes Bridge
Torquay
United Kingdom
TQ2 7AA |
| Sponsor email | sdhct.research@nhs.net |
| Sponsor website | http://www.sdhct.nhs.uk/ |
| Contact name | Dr Tessa Frost |
| Contact details | Dermatology Department
Torbay Hospital
Lawes Bridge
Torquay
United Kingdom
TQ2 7AA |
| Contact email | tessa.frost@nhs.net |
| More information | For more up-to-date information please go to the ISRCTN link below. |
| Link to record in ISRCTN Register | ISRCTN63003238 |
| Date last extracted from ISRCTN register | 17/04/2008 |
